|Batavia Biosciences accelerates the transition of biopharmaceutical product candidates from discovery to the clinic with improved success and lower cost. |
Batavia Biosciences is extensively experienced in developing and improving biopharmaceutical products and production processes. Our strengths include viral vector and protein expression vector construction, generation of viral vaccine seed stocks, mammalian cell line and microbial strain generation, transient protein production, upstream and downstream process optimization, medium development, assay development, product characterization and clinical manufacturing.
Unique technologies like the STEP® expression platform and SCOUT® scaled down analysis technology can be leveraged to accelerate clone selection and development and optimization projects.